This indicator reflects the percentage of women who experienced a live birth within the last two years and utilized
effective preventive measures against malaria during their pregnancy by taking two or more doses of SP/Fansidar, a recommended antimalarial drug. By focusing on this specific medication, the data sheds light on the adherence to malaria prevention guidelines among expectant mothers in endemic regions. Increased usage not only signifies improved access to healthcare resources but also indicates a proactive approach to safeguarding maternal and fetal health against malaria's detrimental effects. Therefore, the percentage serves as a crucial metric for evaluating public health initiatives aimed at reducing malaria prevalence and enhancing maternal health outcomes.
Source: